According to the commonly accepted model, Alzheimer’s disease is characterized by an ineluctable sequence, from the accumulation of toxic proteins in the brain to dementia…
Biogen Inc.’s controversial Alzheimer’s drug Aduhelm produced brain swelling in 35% of patients who took the approved dose, although most didn’t experience symptoms, company researchers…
A team of WA researchers may have discovered a cheap, revolutionary treatment for Alzheimer’s disease—and the key is a body part you may not expect.
Good news for those of us who can’t face the day without their morning flat white: a long-term study has revealed drinking higher amounts of…
No one will disagree that an active lifestyle is good for you, but it remains unclear how physical activity improves brain health, particularly in Alzheimer’s…
U.S. health insurers say they want more proof before paying for Biogen Inc.’s Aduhelm, stalling sales of the costly new Alzheimer’s therapy that the company…
(HealthDay)—Caregivers who provide care to a family member or friend with a health condition or disability are more likely to have subjective cognitive decline (SCD),…
Circadian dysfunction linked to Alzheimer’s disease is known to disrupt sleep and daily activity patterns. New research in a mouse model of the disease suggests…
A study of large-scale functional brain network organization and educational history, led by researchers at the Center for Vital Longevity (CVL), has identified a new…
Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology…